NECLIFE technical summary

At ₹10.14, Nectar Lifesciences Limited is trading 8.4% below its 50-day average of ₹11.07 and 12.3% below its 200-day average of ₹11.57. The 14-day RSI is 42.0, in the neutral range between 30 and 70. MACD is -0.17 against a signal line of -0.16, so the MACD line sits below its signal line. ADX(14) reads 12.3, a weak trend reading (below 20); ADX measures trend strength, not direction. The 52-week range is ₹9.3 to ₹22.4, with the price 6% of the way up it. Classic daily pivot levels from the 3 Nov 2026 session: pivot ₹10.25, resistance ₹10.4 and ₹10.5, support ₹10.15 and ₹10.